AC
LXRX icon

AXQ Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

AXQ Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
45,727
+25,577
+127% +$49.8K 0.01% 826
2026
Q1 		$31.4K Buy
+20,150
New +$29.3K ﹤0.01% 952

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AXQ Capital's LXRX Position: Q2 2026 in Review

AXQ Capital increased its Lexicon Pharmaceuticals (LXRX) stake by 127% in Q2 2026, buying an estimated $49.8K and bringing the position to 45,727 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #826.

AXQ Capital first reported a position in LXRX in Q1 2026 and has held it in 2 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • AXQ Capital held 45,727 shares of Lexicon Pharmaceuticals worth $110K as of Q2 2026.
  • AXQ Capital bought 25,577 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $49.8K.
  • Lexicon Pharmaceuticals made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #826 holding.
  • AXQ Capital first reported a position in Lexicon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.